Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on May 15, 2025

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
Updated clinical data from Emi-Le Phase 1 dose escalation and backfill cohorts presented today at ESMO Breast Cancer 2025 ORR increased to 31% across tumor types among evaluable patients with B7-H4 high tumors receiving intermediate doses Encouraging …

Annual Report and Notice of Meeting
Reykjavík, May 15, 2025 (GLOBE NEWSWIRE) -- (“Amaroq Minerals” or the “Company”) Annual Report and Notice of Meeting TORONTO, ONTARIO – May 15, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a substantial …

Verde Announces Q1 2025 Results
(All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q1 2025: C$1.00 = R$3.93) SINGAPORE, May 15, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) announces its financial results for the …

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
– Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – – RMAT designation granted for rese-cel in myositis, which is a disabling, multi-system autoimmune disease affecting approximately 80,000 U.S. …

Aya Gold & Silver Publishes 2024 Sustainability Report
MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that is has published its 2024 Sustainability Report for the year ended December 31, 2024 (the “Report”). The …

L’usine pilote du Réacteur de Silice Pyrogénée de HPQ franchit un jalon important en produisant un volume significatif de matériaux
MONTRÉAL, 15 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans le développement de nouveaux procédés industriels souhaite informer ses actionnaires …

HPQ Fumed Silica Pilot Produces Significant Material Volumes in Key Milestone
MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company developing next-generation processes for advanced material manufacturing, would like to inform shareholders that …

Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
- Announced robust preclinical data supporting the unique three-pronged mechanism of action of micvotabart pelidotin (MICVO, formerly PYX-201), driving anti-tumor activity via direct tumor killing, bystander effect and immunogenic cell death - On track to …

Oroco Announces Major Initiatives
VANCOUVER, Canada, May 15, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce three pivotal developments that mark significant steps forward for the Company and its flagship Santo Tomás …

REE Automotive Announces Fourth Quarter and Fiscal Year 2024 Earnings Results
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”), an automotive technology company that develops and builds software-defined vehicle technology and a provider of full by-wire electric trucks and …

Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion
Major milestones include entry into cultivated cacao and coffee markets and progress toward commercial-scale production Company reports nearly 400% revenue growth in the first nine months of fiscal year 2025 compared to the same period in fiscal year 2024, …

Parexel Unveils New Industry Report: Global Survey of More Than 500 Pharmaceutical, Biotech and CRO Leaders & Frontline Workers Highlights Key Workforce Trends & Opportunities
Artificial Intelligence (AI) Identified as a Key Area for Continued Workforce Training …

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates
In March 2025, BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic foot osteomyelitis (DFO) BX004 Phase 2b study in Cystic Fibrosis (CF) on track to report topline results in Q1 2026 In April 2025, …

Bon Natural Life Limited Announces Effectiveness of Reverse Stock Split
XI’AN, China, May 15, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that it will effect a …

Esports World Cup Foundation Welcomes OBSBOT as Official Livestream Camera and Webcam Partner for Esports World Cup 2025
Riyadh, Saudi Arabia, May 15, 2025 (GLOBE NEWSWIRE) -- The Esports World Cup Foundation (EWCF) today announced OBSBOT, as an official camera and webcam partner for the Esports World Cup (EWC) 2025, set to return to Riyadh, Saudi Arabia, this summer. The …

AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON
VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) -- AMERICAN SALARS LITHIUM INC. ("AMERICAN SALARS" OR THE "COMPANY") (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY) announces the addition of Dr. Mark King PhD, PGeo, FGC, a world-renowned lithium brine expert, …

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
KUALA LUMPUR, MALAYSIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced its first quarter financial …

FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug exclusive approval from U.S. Food and …